[
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.11,
    "position_percent_raw": "1,11",
    "position_date": "2026-07-22",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.03,
    "position_percent_raw": "1,03",
    "position_date": "2026-07-16",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.92,
    "position_percent_raw": "0,92",
    "position_date": "2026-07-10",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2026-07-03",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2026-06-26",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2026-06-22",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.68,
    "position_percent_raw": "0,68",
    "position_date": "2026-06-12",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2026-06-12",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.78,
    "position_percent_raw": "0,78",
    "position_date": "2026-06-08",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.82,
    "position_percent_raw": "0,82",
    "position_date": "2026-06-05",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.98,
    "position_percent_raw": "0,98",
    "position_date": "2026-05-29",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.82,
    "position_percent_raw": "0,82",
    "position_date": "2026-05-28",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.73,
    "position_percent_raw": "0,73",
    "position_date": "2026-05-27",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.62,
    "position_percent_raw": "0,62",
    "position_date": "2026-05-25",
    "comment": ""
  },
  {
    "holder": "Two Sigma Investments, LP",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.75,
    "position_percent_raw": "0,75",
    "position_date": "2026-05-21",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-03-27",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.37,
    "position_percent_raw": "1,37",
    "position_date": "2026-03-24",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.5,
    "position_percent_raw": "1,5",
    "position_date": "2026-03-20",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.49,
    "position_percent_raw": "1,49",
    "position_date": "2026-03-19",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.87,
    "position_percent_raw": "1,87",
    "position_date": "2026-03-18",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.33,
    "position_percent_raw": "1,33",
    "position_date": "2026-03-17",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2026-03-16",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.54,
    "position_percent_raw": "0,54",
    "position_date": "2026-03-12",
    "comment": ""
  },
  {
    "holder": "Citadel Securities (Europe) Limited",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-01-19",
    "comment": ""
  },
  {
    "holder": "Citadel Securities (Europe) Limited",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.65,
    "position_percent_raw": "0,65",
    "position_date": "2026-01-16",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-10-03",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-09-24",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.02,
    "position_percent_raw": "1,02",
    "position_date": "2025-09-22",
    "comment": ""
  },
  {
    "holder": "GUEVOURA FUND",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.56,
    "position_percent_raw": "0,56",
    "position_date": "2025-09-10",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.24,
    "position_percent_raw": "1,24",
    "position_date": "2025-08-26",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.02,
    "position_percent_raw": "1,02",
    "position_date": "2025-08-22",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.64,
    "position_percent_raw": "0,64",
    "position_date": "2025-08-21",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-08-07",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.72,
    "position_percent_raw": "0,72",
    "position_date": "2025-08-06",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 1.37,
    "position_percent_raw": "1,37",
    "position_date": "2025-08-04",
    "comment": ""
  },
  {
    "holder": "Brummer Multi-Strategy AB",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.82,
    "position_percent_raw": "0,82",
    "position_date": "2025-08-01",
    "comment": ""
  },
  {
    "holder": "Citadel Securities (Europe) Limited",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2024-08-28",
    "comment": ""
  },
  {
    "holder": "Citadel Securities (Europe) Limited",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.56,
    "position_percent_raw": "0,56",
    "position_date": "2024-08-27",
    "comment": ""
  },
  {
    "holder": "Citadel Securities (Europe) Limited",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.64,
    "position_percent_raw": "0,64",
    "position_date": "2024-08-23",
    "comment": ""
  },
  {
    "holder": "Citadel Securities (Europe) Limited",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.74,
    "position_percent_raw": "0,74",
    "position_date": "2024-08-14",
    "comment": ""
  },
  {
    "holder": "Citadel Securities (Europe) Limited",
    "issuer": "Oncopeptides AB",
    "isin": "SE0009414576",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2024-08-12",
    "comment": ""
  }
]